BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33663551)

  • 21. Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
    Grønberg BH; Halvorsen TO; Fløtten Ø; Brustugun OT; Brunsvig PF; Aasebø U; Bremnes RM; Tollåli T; Hornslien K; Aksnessæther BY; Liaaen ED; Sundstrøm S;
    Acta Oncol; 2016 May; 55(5):591-7. PubMed ID: 26494411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis.
    Qi J; Xu L; Sun J; Wang X; Zhao L
    Cancer Manag Res; 2019; 11():10767-10775. PubMed ID: 31920386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
    Patrice GI; Lester-Coll NH; Yu JB; Amdahl J; Delea TE; Patrice SJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):97-106. PubMed ID: 29029885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer.
    Peng J; Zhang L; Wang L; Feng H; Yao D; Meng R; Liu X; Li X; Liu N; Tan B; Huang Z; Li S; Meng X
    Radiat Oncol; 2023 Jul; 18(1):111. PubMed ID: 37403111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
    Hallqvist A; Rylander H; Björk-Eriksson T; Nyman J
    Acta Oncol; 2007; 46(7):969-74. PubMed ID: 17851846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment modality selection and prognosis of early stage small cell lung cancer: retrospective analysis from a single cancer institute.
    Zhu H; Zhou Z; Xue Q; Zhang X; He J; Wang L
    Eur J Cancer Care (Engl); 2013 Nov; 22(6):789-96. PubMed ID: 23763282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
    Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
    Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.
    Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A
    Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
    Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
    Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
    Slotman BJ; Faivre-Finn C; van Tinteren H; Keijser A; Praag J; Knegjens J; Hatton M; van Dam I; van der Leest A; Reymen B; Stigt J; Haslett K; Tripathi D; Smit EF; Senan S
    Lung Cancer; 2017 Jun; 108():150-153. PubMed ID: 28625628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
    Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
    Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy.
    Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L
    J BUON; 2015; 20(1):146-57. PubMed ID: 25778310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
    Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiochemotherapy in extensive disease small cell lung cancer ED-SCLC.
    Jeremic B; Casas F; Wang L; Perin B
    Front Radiat Ther Oncol; 2010; 42():180-186. PubMed ID: 19955805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
    Zayed S; Chen H; Ali E; Rodrigues GB; Warner A; Palma DA; Louie AV
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):575-586. PubMed ID: 32544575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.
    Hasan S; Renz P; Turrisi A; Colonias A; Finley G; Wegner RE
    Lung Cancer; 2018 Oct; 124():283-290. PubMed ID: 30268474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Biologically Effective Dose Radiotherapy for Brain Metastases May Improve Survival and Decrease Risk for Local Relapse Among Patients With Small-Cell Lung Cancer: A Propensity-Matching Analysis.
    Zhuang QY; Li JL; Lin FF; Lin XJ; -Lin H; -Wang Y; -Lin Y; Huang YX; Zhang XQ; Tang LR; Wu JX
    Cancer Control; 2020; 27(2):1073274820936287. PubMed ID: 32614270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of patients with limited small cell lung cancer in whom complete remission was obtained (a non-randomised retrospective study of 124 consecutive patients.
    Wiatr E; Starzynska T; Danczak-Ginalska Z; Zych J; Rowińska-Zakrzewska E
    Lung Cancer; 1995 Oct; 13(2):129-35. PubMed ID: 8581392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world.
    Fang M; Wang L; Gu Q; Wu H; Du X; Lai X
    Clin Exp Metastasis; 2023 Oct; 40(5):423-429. PubMed ID: 37584783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.